Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Harmony Biosciences stock

Learn how to easily invest in Harmony Biosciences stock.

Harmony Biosciences Holdings Inc is a biotechnology business based in the US. Harmony Biosciences shares (HRMY) are listed on the NASDAQ and all prices are listed in US Dollars. Harmony Biosciences employs 150 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Harmony Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HRMY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Harmony Biosciences stock price (NASDAQ: HRMY)

Use our graph to track the performance of HRMY stocks over time.

Harmony Biosciences shares at a glance

Information last updated 2022-01-11.
Latest market close$36.68
52-week range$25.09 - $45.89
50-day moving average $40.26
200-day moving average $34.20
Wall St. target price$57.00
PE ratio 190.6633
Dividend yield N/A (0%)
Earnings per share (TTM) $0.20

Buy Harmony Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
$125 - $625
Open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Harmony Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harmony Biosciences price performance over time

Historical closes compared with the close of $36.68 from 2022-01-14

1 week (2022-01-10) -1.85%
1 month (2021-12-17) -10.23%
3 months (2021-10-15) -6.90%
6 months (2021-07-16) 30.77%
1 year (2021-01-15) -5.51%
2 years (2020-01-13) N/A
3 years (2019-01-13) N/A
5 years (2017-01-13) N/A

Is Harmony Biosciences stock undervalued or overvalued?

Valuing Harmony Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Harmony Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Harmony Biosciences's P/E ratio

Harmony Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 191x. In other words, Harmony Biosciences shares trade at around 191x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Harmony Biosciences's EBITDA

Harmony Biosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $85.1 million.

The EBITDA is a measure of a Harmony Biosciences's overall financial performance and is widely used to measure a its profitability.

Harmony Biosciences financials

Revenue TTM $270.5 million
Operating margin TTM 24.64%
Gross profit TTM $132 million
Return on assets TTM 11.72%
Return on equity TTM 9.47%
Profit margin 4.32%
Book value $2.60
Market capitalisation $2.2 billion

TTM: trailing 12 months

Harmony Biosciences share dividends

We're not expecting Harmony Biosciences to pay a dividend over the next 12 months.

Harmony Biosciences overview

Harmony Biosciences Holdings, Inc. , a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc.

Frequently asked questions

What percentage of Harmony Biosciences is owned by insiders or institutions?
Currently 20.49% of Harmony Biosciences shares are held by insiders and 80.087% by institutions.
How many people work for Harmony Biosciences?
Latest data suggests 150 work at Harmony Biosciences.
When does the fiscal year end for Harmony Biosciences?
Harmony Biosciences's fiscal year ends in December.
Where is Harmony Biosciences based?
Harmony Biosciences's address is: 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
What is Harmony Biosciences's ISIN number?
Harmony Biosciences's international securities identification number is: US4131971040

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site